Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
Authors:
Open Access
- 7 September 2023
- journal article
- review article
- Published by Medknow in Tzu Chi Medical Journal
- Vol. 35 (4) , 290-299
Abstract
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent and challenging disease associated with a significant health and economic burden. MAFLD has been subjected to and widely investigated in many studies; however, the underlying pathogenesis and its progression have yet to understand fully. Furthermore, precise biomarkers for diagnosing and specific drugs for treatment are yet to be discovered. Increasing evidence has proven gut microbiota as the neglected endocrine organ that regulates homeostasis and immune response. Targeting gut microbiota is an essential strategy for metabolic diseases, including MAFLD. Gut microbiota in the gut-liver axis is connected through tight bidirectional links through the biliary tract, portal vein, and systemic circulation, producing gut microbiota metabolites. This review focuses on the specific correlation between gut microbiota metabolites and MAFLD. Gut microbiota metabolites are biologically active in the host and, through subsequent changes and biological activities, provide implications for MAFLD. Based on the review studies, gut-liver axis related-metabolites including short-chain fatty acids, bile acids (BAs), lipopolysaccharide, choline and its metabolites, indole and its derivates, branched-chain amino acids, and methionine cycle derivates was associated with MAFLD and could be promising MAFLD diagnosis biomarkers, as well as the targets for MAFLD new drug discovery.Keywords
This publication has 102 references indexed in Scilit:
- Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cellsNephrology Dialysis Transplantation, 2012
- Plasma free choline is a novel non‐invasive biomarker for early‐stage non‐alcoholic steatohepatitis: A multi‐center validation studyHepatology Research, 2012
- Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in miceHepatology, 2011
- Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver diseaseAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- A human gut microbial gene catalogue established by metagenomic sequencingNature, 2010
- The logic of the hepatic methionine metabolic cycleBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in MiceDiabetes, 2009
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitisJournal of Hepatology, 2007